Western University in London, Ont., is breaking ground on a new centre that researchers say will transform the way the world studies infectious diseases and how it responds to the next pandemic.

Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs, which include a range of products derived from human or animal sources, like recombinant proteins and ...

Viral infections continue to be a leading cause of morbidity and mortality in children. With emerging viruses, evolving resistance patterns, and unique ...

Dirk Görlich and Steven McKnight receive this year's Albert Lasker Award for Basic Medical Research for deciphering the functional principles of ...

Don’t ask, don’t tell” remains the unspoken rule for LGBT service members in Ukraine’s Armed Forces. Hiding their identity protects them from prejudice and risks within their units. But being unable ...

As the annual U.S. Conference on HIV/AIDS (USCHA) kicks off in Washington, D.C., this week with a focus on aging with HIV, Gilead Sciences is rolling out a corresponding awareness campaign ...

Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...

When the U.S. Congress passed the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act in August 1990, it honored a young man who had acquired HIV from a blood transfusion five years earlier ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The Philippines is in the grip of its largest HIV outbreak on record, with 57 new infections reported every day, nearly a third of them among people below 18 years old, Health Secretary Ted Herbosa ...

Patients had better linkage to care for HIV and HIV was more frequently diagnosed when it was tested alongside other sexually transmitted infections (STIs), such as chlamydia and gonorrhea. The study ...

When President Donald Trump began his second term, the world was on the verge of a miracle: ending the global HIV pandemic by 2030. With the first strokes of his pen, Trump set to erase decades of ...